SMS Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 1,353.39 million compared to INR 643.89 million a year ago. Revenue was INR 1,358.52 million compared to INR 651.9 million a year ago.

Net income was INR 93.42 million compared to net loss of INR 127.67 million a year ago. Basic earnings per share from continuing operations was INR 1.1 compared to basic loss per share from continuing operations of INR 1.51 a year ago.